Stimcell Energetics (STME) Shareholder's Equity Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -56.83% |
| Nov 30, 2025 | -56.94% |
| Aug 31, 2025 | -53.40% |
| May 31, 2025 | -50.80% |
| Feb 28, 2025 | -50.75% |
| Nov 30, 2024 | 61.09% |
| Aug 31, 2024 | 63.23% |
| May 31, 2024 | 65.35% |
| Feb 29, 2024 | 69.20% |
| Nov 30, 2023 | -14.83% |
| Aug 31, 2023 | -17.42% |
| May 31, 2023 | -18.74% |
| Feb 28, 2023 | -25.27% |
| Nov 30, 2022 | -28.73% |
| Aug 31, 2022 | -35.43% |
| May 31, 2022 | -27.47% |
| Feb 28, 2022 | 2.63% |
| Nov 30, 2021 | -1.47% |
| Aug 31, 2021 | -4.50% |
| May 31, 2021 | -3.66% |
| Feb 28, 2021 | -28.83% |
| Nov 30, 2020 | -214.72% |
| Aug 31, 2020 | -227.69% |
| May 31, 2020 | 14.23% |
| Feb 29, 2020 | 10.48% |
| Nov 30, 2019 | 202.13% |
| Aug 31, 2019 | 188.50% |
| May 31, 2019 | -65.13% |
| Feb 28, 2019 | -95.36% |
| Nov 30, 2018 | -137.42% |
| Aug 31, 2018 | -27.64% |
| May 31, 2018 | 8.20% |
| Feb 28, 2018 | -8.67% |
| Nov 30, 2017 | -20.62% |
| Aug 31, 2017 | 37.23% |
| May 31, 2017 | 17.22% |
| Feb 28, 2017 | 35.72% |
| May 31, 2014 | -991.81% |
| May 31, 2013 | -117.35% |
| Feb 28, 2013 | -102.82% |
| Nov 30, 2012 | 146.48% |
| May 31, 2012 | 419.24% |